Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) V.S. CVPP PLUS CCNU (CCVPP) in Hodgkin's disease
- 1 May 1979
- Vol. 43 (5) , 1579-1586
- https://doi.org/10.1002/1097-0142(197905)43:5<1579::aid-cncr2820430502>3.0.co;2-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's diseaseCancer, 1976
- Combined chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease.An alternative program to MOPPCancer, 1976
- Improved survival in Hodgkin's diseaseCancer, 1976
- Combined cyclophosphamide, vincristine, procarbazine, and prednisone (copp) therapy of malignant lymphoma.Evaluation of 190 patientsCancer, 1975
- A combined modality approach to the treatment of Hodgkin's disease.Preliminary results of a prospectively randomized clinical trialCancer, 1975
- Combination chemotherapy of Hodgkin's diseaseCancer, 1974
- Combination chemotherapy of advanced Hodgkin's disease.A reviewCancer, 1974
- Combination Chemotherapy in Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1973
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970
- Combined Vinblastine and Chlorambucil Therapy of Hodgkin's DiseaseAnnals of Internal Medicine, 1965